Drug cost mystery: older multiple sclerosis medicines skyrocket despite competition

April 25, 2015 2:58 PM

4 0

A group of Oregon researchers have issued what amounts to an indictment of pharmaceutical industry pricing, with a new study showing that people with multiple sclerosis have been hit with skyrocketing bills for medicines introduced long ago.

A group of Oregon researchers have issued what amounts to an indictment of pharmaceutical industry pricing, with a new study showing that people with multiple sclerosis have been hit with skyrocketing bills for medicines introduced long ago.

Read more

To category page

Loading...